Asia Pacific Kidney Function Tests Market By Product, By End Use, By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027

The Asia Pacific Kidney Function Tests Market is expected to witness market growth of 8.9% CAGR during the forecast period (2021-2027).

In order to evaluate different aspects of kidney function, there are various kinds of kidney function tests. A kidney function test is carried out to confirm whether the kidneys are filtering waste components very slowly and to check if the kidney is pushing proteins into the urine. Regular kidney function tests could assist in recognizing problems like kidney disease in the initial stages, thereby providing an opportunity to stop the further development of the disease. Urine tests, imaging tests, blood tests, and kidney biopsy are some of the popular kidney function tests.

As per the National Kidney Foundation, approximately 37 million individuals are affected by chronic kidney diseases across the United States and 1 in 3 American adults; around 80 million individuals are vulnerable to develop chronic kidney disease. Moreover, around 3 million individuals around the globe are suffering from End-stage renal disease, and hence the number of patients diagnosed with the disease keeps on increasing at a rapid rate. Economies like Japan, Taiwan, and other Asian countries witnessed the maximum prevalence rate of CKD. The prime catalysts for the growth & demand of kidney function tests are the rising alcohol consumption, growing rates of hypertension, diabetes, and obesity, shift to an inactive lifestyle, and a growing number of supportive governmental initiatives for the notice and treatment of kidney diseases.

The Clearance Test market dominated the Malaysia Kidney Function Tests Market by Product in 2020, thereby, achieving a market value of $5.6 million by 2027. The Blood Tests market is exhibiting a CAGR of 9.5% during (2021 - 2027). Additionally, The Urine Tests market is expected to witness highest CAGR of 11.8% during (2021 - 2027).

Based on Product, the market is segmented into Clearance Test, Blood Tests, Urine Tests, Dilution & Concentration Tests, and Others. Based on End Use, the market is segmented into Hospitals, Diagnostic Laboratories, Research Laboratories and Institutes and others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens AG, Randox Laboratories Limited, Quest Diagnostics, Incorporated, Laboratory Corporation of America holdings, Sysmex Corporation, ACON Laboratories, Inc., and Nova Biomedical Corporation.

Scope of the Study

Market Segments covered in the Report:

By Product

• Clearance Test
• Blood Tests
• Urine Tests
• Dilution & Concentration Tests,
• Others

By End Use

• Hospitals
• Diagnostic Laboratories
• Research Laboratories and Institutes
• others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Companies Profiled

• Abbott Laboratories
• Danaher Corporation
• F. Hoffmann-La Roche Ltd.
• Siemens AG
• Randox Laboratories Limited
• Quest Diagnostics, Incorporated
• Laboratory Corporation of America holdings
• Sysmex Corporation
• ACON Laboratories, Inc.
• Nova Biomedical Corporation

Unique Offerings from the Publisher

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free